Form 4 for BSX Boston Scientific
Accepted 2021-12-21 00:00:00 ET · period of report 2021-12-20 · accession 0001225208-21-015180 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-21 | 2021-12-20 | BSX | Pierce David A | EVP Pres MedSurg | S - Sale+OE | $39.90 | -50.0K | 0 | -100% | -$1.99M |
| DM | 2021-12-21 | 2021-12-20 | BSX | Pierce David A | EVP Pres MedSurg | M - OptEx | $7.27 | +47.9K | 50.0K | +2,330% | +$348.7K |
| DM | 2021-12-21 | 2021-12-20 | BSX | Pierce David A | EVP Pres MedSurg | M - OptEx | $0.00 | -47.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-20 | S | D | 49,988 | $39.90 | 0 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.47 to $40.31, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2021-12-20 | M | A | 42,934 | $7.39 | 44,991 | D | — | — | |
| 3 | Common | Common Stock | 2021-12-20 | M | A | 4,997 | $6.28 | 49,988 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-12-20 | M | D | 4,997 | $0.00 | 0 | D | $6.28 · — to 2022-02-27 | 4,997 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-12-20 | M | D | 42,934 | $0.00 | 0 | D | $7.39 · — to 2023-02-28 | 42,934 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant. |